drugset / Trial / NCT01913158

Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids

NCT01913158

Phase 2 Completed 150 enrolled G & W Laboratories Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study is to determine the safety and efficacy of G\&W Laboratories' Anucort HC TM (Hydrocortisone Acetate) 25mg Rectal Suppositories in subjects with internal hemorrhoidal symptoms.

Timeline

Start
2013-10
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 25 mg Rectal

Indications